Abstract
The identification of novel genes or groups of genes expressed in prostate cancer may allow earlier diagnosis or more accurate staging of the disease. We describe the assembly and use of a 1877-member microarray representing cDNA clones from a range of prostate cancer stages and grades, precursor lesions and normal tissue. Using labelled cDNA from tumour samples obtained from TURP or radical prostatectomy, analysis of expression patterns identified many up-regulated transcripts. Cell lines were found to over-express fewer genes than diseased tissue samples. 17 known genes were found to over-express more than 4-fold in 4 or more cancers out of 15 cancers. Only 2 genes were over-expressed in 6 out of 15 cancers or more, whilst no genes were consistently found to be over-expressed in all cancer samples. Novel prostate cancer associations for several well characterized genes or full length cDNAs were identified, including PLRP1, JM27, human UbcM2, dynein light intermediate chain 2 and human homologue of rat sec61. Novel associations with high-grade PIN include: breast carcinoma fatty acid synthase and cDNA DKFZp434B0335. We shortlist and discuss the most significant over-expressed genes in prostate cancer and PIN, and highlight expression differences between malignant and benign samples. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Al-Hashim I, Dickinson DP and Levine MJ (1988) Purification, molecular cloning, and sequencing of salivary cystatin SA-1. J Biol Chem 263: 9381–9387
Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D and Levine AJ (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96: 6745–6750
Bertucci F, Van Hulst S, Bernard K, Loriod B, Granjeaud S, Tagett R, Starkey M, Nguyen C, Jordan B and Birnbaum D (1999) Expression scanning of an array of growth control genes in human tumor cell lines. Oncogene 18: 3905–3912
Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R and Vidaud M (1999) Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45 (8 Pt 1): 1148–1156
Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB and Nelson WG (1998) CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 7: 531–536
Buckbinder L, Talbott R, Seizinger BR and Kley N (1994) Gene regulation by temperature-sensitive p53 mutants: identification of p53 response genes. Proc Natl Acad Sci USA 91: 10640–10644
Burckzac JD, Cafferkey R and Wilkinson FE (1998) Leveraging genomics for the discovery of diagnostic markers. J Clin Ligand Assay 21: 47–57
Catalona WJ, Smith DS, Ratcliff TL and Basler JW (1993) Detection of organ-confined prostate cancer is increased by prostate specific antigen-based screening. JAMA 270: 948–954
Church GM and Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81: 1991–1995
Crawford DE, DeAntoni E and Ross CA (1996) The role of prostate-specific antigen in the chemoprevention of prostate cancer. J Cell Biochem 25S: 149–155
da Silva AJ, Li Z, de Vera C, Canto E, Findell P and Rudd CE (1997) Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc Natl Acad Sci USA 94: 7493–7498
Dalton S and Treisman R (1992) Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68: 597–612
Didsbury JR, Ho YS and Snyderman R (1987) Human Gi protein alpha-subunit: deduction of amino acid structure from a cloned cDNA. FEBS Lett 211: 160–164
Giller T, Buchwald P, Blum-Kaelin D and Hunziker W (1992) Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity. J Biol Chem 267: 16509–16516
Gleason D (1993) Histological grading of prostate cancer: a perspective. Human Pathology 23: 273–279
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531–537
Gong W, Emanuel BS, Collins J, Kim DH, Wang Z, Chen F, Zhang G, Roe B and Budarf ML (1996) A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum Mol Genet 5: 789–800
Haggman MJ, Macoska JA, Wojno KJ and Oeserling JE (1997) The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J Urol 158: 12–22
Hegarty NJ, Fitzpatrick JM, Richie JP, Scardino PT, deVere White RW, Schroder FH and Coffey DS (1999) Future prospects in prostate cancer. The Prostate 40: 261–268
Imataka H, Olsen HS and Sonenberg N (1997) A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J 16: 817–825
Jarmulowicz MR (1999) The role of pathology in biopsy, diagnosis and management of prostate cancer. In: Textbook of Prostate Cancer, Kaisary AV, Murphy GP, Denis L and Griffiths K (eds) pp 17–33. Martin Dunitz: London
Jaiswal AK, Gonzalez FJ and Nebert DW (1985) Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. Science 228: 80–83
Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ and Mann KG (1987) Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84: 4846–4850
Jones WG and Smith PH (1994) Cancer of the Prostate. In: Manual of Clinical Oncology, sixth edition, Love et al (eds) pp. 409–418. Springer-Verlag: Berlin
Kahn S, Yamamoto F, Almoguera C, Winter E, Forrester K, Jordano J and Perucho M (1987) The c-K-ras gene and human cancer. Anticancer Res 7(4A): 639–652
Kallunki T, Ikonen J, Chow LT, Kallunki P and Tryggvason K (1991) Structure of the human laminin B2 chain gene reveals extensive divergence from the laminin B1 chain gene. J Biol Chem 266: 221–228
Kamine J, Elangovan B, Subramanian T, Coleman D and Chinnadurai G (1996) Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216: 357–366
Kay R, Rosten PM and Humphries RK (1991) CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol 147: 1412–1416
Landis SH, Murray T, Bolden S and Wingo PA (1998) Cancer statistics. Cancer J Clin 48: 6–29
Menon M (1997) Predicting biological aggressiveness in prostate cancer-desperately seeking a marker. J Urol 157: 228–229
Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P and Katzenellenbogen BS (1999) An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci USA 96: 6947–6952
Nomiyama H, Fukuda S, IioM Tanase S, Miura R and YoshieO (1999) Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC, and RANTES. J Interferon Cytokine Res 19: 227–234
Reeves WH and Sthoeger ZM (1989) Molecular cloning of cDNA encoding the p70 (Ku) lupus autoantigen. J Biol Chem 264: 5047–5052
Ren Y, Busch RK, Perlaky L and Busch H (1998) The 58-kDa microspherule protein (MSP58), a nucleolar protein, interacts with nucleolar protein p120. Eur J Biochem 253: 734–742
Rokeach LA, Haselby JA, Meilof JF, Smeenk RJ, Unnasch TR, Greene BM and Hoch SO (1991) Characterization of the autoantigen calreticulin. J Immunol 147: 3031–3039
Sagar R (1997) Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 94: 952–955
Screaton GR, Caceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI and Krainer AR (1995) Identification and characterization of three members of the human SRRT family of pre-mRNA splicing factors. EMBO J 14: 4336–4349
Scott IC, Halila R, Jenkins JM, Mehan S, Apostolou S, Winqvist R, Callen DF, Prockop DJ, Peltonen L and Kadler KE (1996) Molecular cloning, expression and chromosomal localization of a human gene encoding a 33 kDa putative metallopeptidase (PRSM1). Gene 174: 135–143
Srivastava M, McBride OW, Fleming PJ, Pollard HB and Burns AL (1990) Genomic organization and chromosomal localization of the human nucleolin gene. J Biol Chem 265: 14922–14931
Talalay P (1989) Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv Enzyme Regul 28: 237–250
Walker MG, Volkmuth W, Sprinzak E, Hodgson D and Klinger T (1999) Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes. Genome Res 9: 1198–1203
Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L and Mulligan J (1999) Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229: 101–108
Zazzi H, Nikoshkov A, Hall K and Luthman H (1998) Structure and transcription regulation of the human insulin-like growth factor binding protein 4 gene (IGFBP4). Genomics 49: 401–410
Zhang L, Zhoe W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW (1997) Gene expression profiles in normal and cancer cells. Science 276: 1268–1272
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bull, J., Ellison, G., Patel, A. et al. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 84, 1512–1519 (2001). https://doi.org/10.1054/bjoc.2001.1816
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1816
Keywords
This article is cited by
-
Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics
Cancer Cell International (2019)
-
[11C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice
Molecular Imaging and Biology (2016)
-
Genome-wide analysis of microRNA and mRNA expression signatures in cancer
Acta Pharmacologica Sinica (2015)
-
LNCaP Atlas: Gene expression associated with in vivoprogression to castration-recurrent prostate cancer
BMC Medical Genomics (2010)
-
JM-27: A biomarker for symptomatic benign prostatic hyperplasia and lower urinary tract symptoms
Current Prostate Reports (2008)